HPV-AHEAD

Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe

 Coordinatore CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER 

 Organization address address: Cours Albert-Thomas 150
city: LYON CEDEX 08
postcode: 69372

contact info
Titolo: Dr.
Nome: Olaf
Cognome: Kelm
Email: send email
Telefono: +33 4 72738494

 Nazionalità Coordinatore France [FR]
 Sito del progetto http://hpv-ahead.iarc.fr/
 Totale costo 4˙192˙381 €
 EC contributo 2˙999˙946 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2011-single-stage
 Funding Scheme CP-FP
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-09-01   -   2015-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

 Organization address address: Cours Albert-Thomas 150
city: LYON CEDEX 08
postcode: 69372

contact info
Titolo: Dr.
Nome: Olaf
Cognome: Kelm
Email: send email
Telefono: +33 4 72738494

FR (LYON CEDEX 08) coordinator 1˙217˙848.80
2    DEUTSCHES KREBSFORSCHUNGSZENTRUM

 Organization address address: Im Neuenheimer Feld 280
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Ms.
Nome: Bettina
Cognome: Crispin
Email: send email
Telefono: +49 622 142 2700
Fax: +49 622 142 2708

DE (HEIDELBERG) participant 424˙272.00
3    ISTITUTO EUROPEO DI ONCOLOGIA SRL

 Organization address address: Via Filodrammatici 10
city: MILANO
postcode: 20121

contact info
Titolo: Ms.
Nome: Ilaria
Cognome: Foti
Email: send email
Telefono: 390257000000
Fax: 390294000000

IT (MILANO) participant 217˙800.00
4    INSTITUT CATALA D'ONCOLOGIA

 Organization address address: "AVDA. Gran Via KM 2,7 S/N"
city: "HOSPITALET DEL LLOBREGAT, BARCELONA"
postcode: 8907

contact info
Titolo: Ms.
Nome: Cristina
Cognome: Rajo Anadón
Email: send email
Telefono: +34 93 2607109

ES ("HOSPITALET DEL LLOBREGAT, BARCELONA") participant 200˙958.00
5    UNIVERSITEIT ANTWERPEN

 Organization address address: PRINSSTRAAT 13
city: ANTWERPEN
postcode: 2000

contact info
Titolo: Ms.
Nome: Anne
Cognome: Adams
Email: send email
Telefono: +32 3 265 30 28
Fax: +32 3 265 30 11

BE (ANTWERPEN) participant 200˙004.00
6    DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG POTSDAM REHBRUECKE

 Organization address address: Arthur-Scheunert-Allee 114-116
city: NUTHETAL
postcode: 14558

contact info
Titolo: Dr.
Nome: Judith
Cognome: Schaefer
Email: send email
Telefono: +49 33200 88292
Fax: +49 33200 88509

DE (NUTHETAL) participant 199˙285.00
7    UNIVERSITAETSKLINIKUM HEIDELBERG

 Organization address address: IM NEUENHEIMER FELD 672
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Mr.
Nome: Thorsten
Cognome: Brietz
Email: send email
Telefono: +49 6221 567086
Fax: +49 6221 565460

DE (HEIDELBERG) participant 181˙800.00
8    ARISTOTELIO PANEPISTIMIO THESSALONIKIS

 Organization address address: Administration Building, University Campus
city: THESSALONIKI
postcode: 54124

contact info
Titolo: Ms.
Nome: Georgia
Cognome: Petridou
Email: send email
Telefono: 302311000000
Fax: 302311000000

EL (THESSALONIKI) participant 149˙960.00
9    RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY

 Organization address address: MILLENIUM PARKWAY JAGATHY
city: THIRUVANANTHAPURAM
postcode: 695 014

contact info
Titolo: Mr.
Nome: Rajan
Cognome: Panicker
Email: send email
Telefono: +91 471 2345776
Fax: +91 471 2348096

IN (THIRUVANANTHAPURAM) participant 110˙000.00
10    ROCHE MTM LABORATORIES AG

 Organization address address: IM NEUENHEIMER FELD 583
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Mrs.
Nome: Karin
Cognome: Mueller
Email: send email
Telefono: +49 6221 64966 118
Fax: +49 6221 64966 10

DE (HEIDELBERG) participant 98˙018.20
11    FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

 Organization address address: AVENIDA GRAN VIA HOSPITALET 199-203
city: L'HOSPITALET DE LLOBREGAT
postcode: 8908

contact info
Titolo: Ms.
Nome: Victoria
Cognome: Cochrane
Email: send email
Telefono: 34932607226
Fax: 34932607224

ES (L'HOSPITALET DE LLOBREGAT) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

hnc    indian    addition    prognosis    tissues    natural    papillomavirus    epidemiological    worldwide    history    infection    screening    hpv    decades    head    human    risk    positive    proportion    oral    countries    ahead    vaccinated    centres    infections    treatment    cancer    determine    steadily    neck    strategies   

 Obiettivo del progetto (Objective)

'Human papillomavirus (HPV) is responsible for approximately 25% of head and neck cancer (HNC) worldwide and appears to be associated with a better response to treatment and improved prognosis. Evidence suggests that HPV-induced HNC has steadily increased in the USA and some European countries in the last decades. However, whether this is a worldwide phenomenon and specific risk factors are associated with it remains to be proven. In addition, little is known on the natural history and risk factors of oral HPV infection. HPV-AHEAD network aims to address these and other unanswered questions on HNC etiology and epidemiology with a focus on the role of HPV. We will assemble and analyze a large collection of plasma/sera and HNC tissues from 42 centres in 16 European countries as well as HNC tissues from 7 Indian centres together with epidemiological and clinical data. HPV status in human specimens will be evaluated by different assays in central laboratories. Epidemiological studies will be conducted to establish the overall proportion and type distribution of HPV-positive HNC at different anatomical sites in European and Indian regions as well as the time trend of the proportion of HPV-positive HNC in recent decades. Using the follow-up information on HNC patients, we will further investigate whether HPV positivity confers a better prognosis and survival. We will also conduct a study in HPV-vaccinated and non-vaccinated women in order to determine risk factors and natural history of oral HPV infections. In addition, we will search for new surrogate markers for oral HPV infection to facilitate novel screening strategies. Finally, the HPV-AHEAD consortium aims to transfer technology to Indian centres as well as to develop several strategies for the training of European and Indian researchers in infections and cancers. This study will provide important insights for the screening, diagnosis, treatment and prophylaxis of HPV-associated HNC in Europe, India and elsewhere.'

Introduzione (Teaser)

The steadily increasing incidence of head and neck cancer (HNC) in Europe and the United States highlights the need to determine causative factors. Researchers are working on deciphering the role of human papillomavirus (HPV) infection in HNC development.

Altri progetti dello stesso programma (FP7-HEALTH)

AMPHORA (2009)

Alcohol Measures for Public Health Research Alliance (AMPHORA)

Read More  

ORCAB (2009)

Improving quality and safety in the hospital: The link between organisational culture, burnout, and quality of care

Read More  

DEVELOPAKURE (2012)

Clinical Development of Nitisinone for Alkaptonuria

Read More